Ichthyosis
MONDO:0019269Disorders of cornification that are characterized by visible scaling and/or hyperkeratosis of most or all of the skin. Inherited ichthyoses, defined as the generalized form of Mendelian disorders of cornification, affect most or all of the skin. This etiologically and phenotypically heterogenous group of conditions is caused by mutations in various different genes important for keratinocyte differentiation and epidermal barrier function. Acquired forms of ichthyosis can be observed with certain autoimmune, inflammatory, metabolic, endocrine, or infectious diseases or with malignancies.
Also known as: DOC, disorder of cornification, fish scale disease, fish skin disease, ichthyosis, ichthyosis (disease), non-syndromic ichthyosis
41 clinical trials for this condition and its sub-types, 13 tagged with Ichthyosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Ichthyosis
-
Inherited ichthyosis 6 trials · 33 incl. sub-types
13 sub-types
- Netherton syndrome 16 trials
- Autosomal recessive congenital ichthyosis 2 trials · 10 incl. sub-types Sub-types →
- Keratinopathic ichthyosis 0 trials · 7 incl. sub-types Sub-types →
- Ichthyosis vulgaris 3 trials Sub-types →
- Recessive X-linked ichthyosis 2 trials Sub-types →
- Peeling skin syndrome 1 trial Sub-types →
- IFAP syndrome 0 trials Sub-types →
- Congenital cataract-ichthyosis syndrome 0 trials
- Ichthyosis hystrix 0 trials Sub-types →
- Ichthyosis linearis circumflexa 0 trials
- Ichthyosis with erythrokeratoderma 0 trials
- Ichthyosis-oral and digital anomalies syndrome 0 trials
- Neonatal ichthyosis-sclerosing cholangitis syndrome 0 trials
-
Acquired ichthyosis 0 trials
-
Ichthyosis, follicular 0 trials
Most studied deeper sub-types
-
Live bacteria cream shows promise for rare skin disease
Disease control CompletedThis early-stage trial tests a cream called ATR12-351 for Netherton syndrome, a rare genetic skin condition. The cream contains live bacteria that produce a protein missing in people with the disease. Twelve adults will apply the cream to one side of their body and a placebo to t…
Phase 1 • Sponsor: Azitra Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New ointment shows promise for rare skin condition
Disease control CompletedThis Phase 3 study tested an ointment called TMB-001 in 153 people aged 6 and older with X-linked or ARCI ichthyosis, conditions that cause dry, scaly, and cracked skin. Participants applied the ointment or a placebo daily for 12 weeks, with some continuing for maintenance. The g…
Phase 3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Experimental pill targets toxic fat buildup in rare genetic disease
Disease control CompletedThis study tested an oral drug called ADX-629 in 8 people with Sjögren-Larsson syndrome, a rare inherited disorder that causes harmful fatty substances to build up in the skin, brain, and eyes. The main goals were to see if the drug is safe and can reduce these fatty aldehydes. P…
Phase 1/2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
AI listens in to free up Doctors' time
Knowledge-focused CompletedThis study tested an AI voice assistant that listens to conversations between neurologists and patients, then automatically fills out electronic medical records. Researchers timed 320 visits with and without the AI to see if it saved doctors time and improved patient care. The go…
Sponsor: Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Hidden eye problems found in ichthyosis patients
Knowledge-focused CompletedThis study examined 152 people with hereditary ichthyosis to find out how common eye problems are. Participants received a full eye exam, including tests for dry eye, corneal shape, and vision. The goal was to detect hidden issues like keratoconus, which can lead to vision loss i…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC